Ratings Surperformance

Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - DR Horton

Ratings ESG MSCI

Ratings ESG MSCI - DR Horton

Ratings DR Horton: Strengths and Weaknesses

Weaknesses: DR Horton
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The group usually releases earnings worse than estimated.

Rating Financials

DR Horton SectorMexico

Fundamentals

Growth

Revenue growth

EPS growth

FCF growth

Profitability

EBITDA Margin

EBIT Margin

Net Margin

Capital Efficiency

ROA

ROCE

ROE

Financial Health

Gearing

Leverage

Capital Intensity

Balance sheet growth

Long Term balance sheet growth

Long term revenue growth

Long term EPS growth

More ratings
Fundamental Rankings - DR Horton

Rating Valuation

DR Horton SectorMexico

Global Valuation

Enterprise Value

EV/Revenue

EV/EBITDA

EV/FCF

Equity Valuation

P/E

PBR

Dividend Yield

EV/EBIT

CAPEX/Revenue

More ratings
Fundamental Rankings - DR Horton

Rating Consensus

DR Horton SectorMexico

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (1 year)

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (1 year)

Analysts' target price evolution (4 months)

Analysts' recommendations evolution (7 days)

Target Price evolution (7 days)

More ratings
Fundamental Rankings - DR Horton

Rating Business Predictability

DR Horton SectorMexico

Visibility

Analysts' coverage

Financial estimates divergence

Analysts' recommendations divergence

Analysts' Target price divergence

Surprise rates

Fundamental Rankings - DR Horton

Rating Revisions

DR Horton SectorMexico

Financial revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

EPS revisions (1 year)

EPS revisions (4 months)

EPS revisions (7 days)

Revenue revisions (7 days)

More ratings
Fundamental Rankings - DR Horton


Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
37.28B
AA
37.28B
AA
21.06B
AA
18.1B
BB
16.86B
AA
15.81B
A
13.61B
AAA
12.33B
BBB
6.47B
AAA
6.31B - - - - - - -
Average 18.51B
AA
Weighted average by Cap.
AA